List of works - Michael Tranter

Activation of HuR downstream of p38 MAPK promotes cardiomyocyte hypertrophy

scientific article published on 10 August 2016

Acute consumption of a high-fat diet prior to ischemia-reperfusion results in cardioprotection through NF-κB-dependent regulation of autophagic pathways.

scientific article

Anti-inflammatory effects of HO-1 activity in vascular endothelial cells, commentary on "Carbon monoxide donors or heme oxygenase (HO-1) overexpression blocks interleukin-18-mediated NF-kappaB-PTEN-dependent human cardiac endothelial cell death"

scientific article published on 07 November 2007

Complementary, alternative, and putative nontroponin biomarkers of acute coronary syndrome: new resources for future risk assessment calculators

scientific article

Coordinated post-transcriptional regulation of Hsp70.3 gene expression by microRNA and alternative polyadenylation

scientific article

Differential translocation of nuclear factor-kappaB in a cardiac muscle cell line under gravitational changes.

scientific article published on June 2009

HuR expression in adipose tissue mediates energy expenditure and acute thermogenesis independent of UCP1 expression

scientific article published on 01 December 2020

Human antigen R as a therapeutic target in pathological cardiac hypertrophy

scientific article published on 21 February 2019

Identification of a NF-κB cardioprotective gene program: NF-κB regulation of Hsp70.1 contributes to cardioprotection after permanent coronary occlusion

scientific article published on 23 March 2011

In Vivo Delivery of Nucleic Acids via Glycopolymer Vehicles Affords Therapeutic Infarct Size Reduction In Vivo ⬇️

scientific article published on December 20, 2011

Increased fibrosis and progression to heart failure in MRL mice following ischemia/reperfusion injury

scientific article published on 13 June 2014

Mechanisms linking adipose tissue inflammation to cardiac hypertrophy and fibrosis

scientific article published on 01 November 2019

NF-kappaB driven cardioprotective gene programs; Hsp70.3 and cardioprotection after late ischemic preconditioning.

scientific article published on 16 July 2010

PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.

scientific article published on 29 March 2018

Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model.

scientific article

Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation ⬇️

scientific article published on April 27, 2012

Reply to Christians: Hsf1 Knock-out.

scientific article published in December 2011

Synthesis and PGE2 inhibitory activity of novel diarylheptanoids.

scientific article published on 21 December 2017

The history and future of probenecid.

scientific article published on March 2012

The stress-induced heat shock protein 70.3 expression is regulated by a dual-component mechanism involving alternative polyadenylation and HuR

scientific article published on 26 February 2015

Tranilast Blunts the Hypertrophic and Fibrotic Response to Increased Afterload Independent of Cardiomyocyte Transient Receptor Potential Vanilloid 2 Channels

scientific article published on 01 July 2018

List of works by Michael Tranter

Activation of HuR downstream of p38 MAPK promotes cardiomyocyte hypertrophy

Acute consumption of a high-fat diet prior to ischemia-reperfusion results in cardioprotection through NF-κB-dependent regulation of autophagic pathways.

Anti-inflammatory effects of HO-1 activity in vascular endothelial cells, commentary on "Carbon monoxide donors or heme oxygenase (HO-1) overexpression blocks interleukin-18-mediated NF-kappaB-PTEN-dependent human cardiac endothelial cell death"

Complementary, alternative, and putative nontroponin biomarkers of acute coronary syndrome: new resources for future risk assessment calculators

Coordinated post-transcriptional regulation of Hsp70.3 gene expression by microRNA and alternative polyadenylation

Differential translocation of nuclear factor-kappaB in a cardiac muscle cell line under gravitational changes.

HuR expression in adipose tissue mediates energy expenditure and acute thermogenesis independent of UCP1 expression

Human antigen R as a therapeutic target in pathological cardiac hypertrophy

Identification of a NF-κB cardioprotective gene program: NF-κB regulation of Hsp70.1 contributes to cardioprotection after permanent coronary occlusion

In Vivo Delivery of Nucleic Acids via Glycopolymer Vehicles Affords Therapeutic Infarct Size Reduction In Vivo ⬇️

Increased fibrosis and progression to heart failure in MRL mice following ischemia/reperfusion injury

Mechanisms linking adipose tissue inflammation to cardiac hypertrophy and fibrosis

NF-kappaB driven cardioprotective gene programs; Hsp70.3 and cardioprotection after late ischemic preconditioning.

PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.

Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model.

Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation ⬇️

Reply to Christians: Hsf1 Knock-out.

Synthesis and PGE2 inhibitory activity of novel diarylheptanoids.

The history and future of probenecid.

The stress-induced heat shock protein 70.3 expression is regulated by a dual-component mechanism involving alternative polyadenylation and HuR

Tranilast Blunts the Hypertrophic and Fibrotic Response to Increased Afterload Independent of Cardiomyocyte Transient Receptor Potential Vanilloid 2 Channels